RELISTOR

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug RELISTOR contains one active pharmaceutical ingredient (API):

1 Methylnaltrexone UNII RFO6IL3D3M - METHYLNALTREXONE BROMIDE

Methylnaltrexone bromide is a selective antagonist of opioid binding at the mu-receptor. As a quaternary amine, the ability of methylnaltrexone bromide to cross the blood-brain barrier is restricted. This allows methylnaltrexone bromide to function as a peripherally acting mu-opioid antagonist in tissues such as the gastrointestinal tract, without impacting opioid-mediated analgesic effects on the central nervous system. Read about Methylnaltrexone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RELISTOR Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AH01	Methylnaltrexone	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AH Peripheral opioid receptor antagonists
Discover more medicines within A06AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5423K, 5424L
Country: CA	Health Products and Food Branch	Identifier(s): 02308215
Country: EE	Ravimiamet	Identifier(s): 1345878, 1348433, 1361696, 1493850, 1493861, 1493872, 1493883, 1493894, 1493906, 1493917, 1493928
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08463001, 08463003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 453862, 503645
Country: FR	Base de données publique des médicaments	Identifier(s): 60594326
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 137996, 137997
Country: IE	Health Products Regulatory Authority	Identifier(s): 43711, 43734
Country: IT	Agenzia del Farmaco	Identifier(s): 038600019, 038600021, 038600033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1033291, 1033292, 1033293, 1056507, 1056508, 1056509, 1056510, 1056511, 1056512, 1056513, 1056514
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86754
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16300
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100198105, 100235958, 100235964
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W53320001, W53320002, W53320003
Country: SG	Health Sciences Authority	Identifier(s): 13783P
Country: US	FDA, National Drug Code	Identifier(s): 65649-150, 65649-551